Illumina (WBO:ILMN) Valuation Rank


WBO:ILMN Illumina Inc WBO:ILMN
70 GF Score
Price €154.82
GF Value €113.28
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Illumina Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Illumina Valuation Rank Related Terms

WBO:ILMN
70GF Score
Illumina Inc WBO:ILMN
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Illumina (WBO:ILMN) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of €154.82 is trading 36.7% above its estimated GF Value™ of €113.28. GuruFocus considers Illumina to be Significantly Overvalued.

Key valuation signals for WBO:ILMN:

  • Valuation Rank:
  • GF Value™: €113.28 vs. price of €154.82 (36.7% above fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the WBO:ILMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
70GF Score

Get the complete analysis for WBO:ILMN

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€154.82
Price
€113.28
GF Value